Batch: Fall 2024
Simplifying Glaucoma Care: Monthly Eyedrops for Improved Patient Compliance
Contact person: Stanislav Kalinin
Batch: Fall 2024
AI-based rapid feature extraction transforming medical big brain data into usable format
Contact person: Harri Merisaari
Batch: Fall 2024
Developing an augmented reality solution to empower elderly individuals to live longer, healthier, and more active lives in their own homes.
Contact person: Timo Niskanen
Batch: Fall 2024
Cornea Sense aims to improve cornea health diagnostic by directly measuring cornea hydration levels for better patient outcomes and treatment
Contact person: Anton Chernenko
Batch: Fall 2024
A stand that allows easier casting and better performance in limb procedures.
Contact person: Pekka Nätti
Batch: Spring 2024
Opportunistic Screening of Alzheimer's Disease Using Retinal Imaging
Contact person: Sebastian Högnabba
Batch: Spring 2024
Developing MYC-dependency targeting drugs to treat cancer
Contact person: Juha Klefström
Batch: Spring 2024
Development of powerful protein-based vaccine technologies
Contact person: Minna Hankaniemi
Batch: Spring 2024
Validation of biomarkers for the detection of stroke type and onset.
Contact person: Helike Lõhelaid
Batch: Spring 2024
Development of novel cellular stress regulators for the treatment of neurological and metabolic diseases
Contact person: Vera Kovaleva
Batch: Spring 2024
Pocket sized microscope that solves the challenges faced by research and diagnostic labs.
Contact person: Igor Shevkunov
Batch: Fall 2023
Developing pathophysiologically relevant in vitro models for human neurodegenerative disorders for drug discovery
Contact person: Joel Noutere
Batch: Fall 2023
A novel, non-invasive approach for cancer screening and diagnosis
Contact person: Andrew Erickson
Batch: Fall 2023
Timely diagnostics of developmental conditions with eye tracking
Contact person: Anna Ptukha
Batch: Fall 2023
Developing and new tumour-specific agent designed to diagnose and treat metastatic brain tumours.
Contact person: Pirjo Laakkonen
Batch: Fall 2023
Accelerating preclinical epilepsy drug development with brain-on-chip
Contact person: Susanna Narkilahti
Batch: Fall 2023
Cancer immunotherapy testing on a chip
Contact person: Heidi Haikala
Batch: Spring 2023
Developing new immunotherapies for cancer
Contact person: Carlos Rogerio Figueiredo
Batch: Spring 2023
Immunoliposomes to detect rupture prone intracranial aneurysms
Contact person: Behnam Rezai Jahromi
Batch: Spring 2023
Non-invasive method to diagnose intestinal diseases
Contact person: Lauri Polari
Batch: Spring 2023
Intra-articular calcipotriol for treatment of (osteo)arthritis
Contact person: Johanna Huhtakangas
Batch: Spring 2023
Digital therapeutics treatment for fear of childbirth
Contact person: Annika Järvelin
Batch: Spring 2023
DNA Nanoswitches-enabled Visual Colorimetric Diagnostics
Contact person: Jacky Loo
Batch: Spring 2023
Next-generation bioinks for 3D bioprinting living tissues and organs
Contact person: Anni Mörö
Batch: Spring 2023
Improved early-stage cancer detection and sensitive disease monitoring
Contact person: Pyry Helkkula
Batch: Spring 2023
Early intervention for hearing health
Contact person: Tanja Tervonen
Batch: Spring 2023
Novel method for optimized and personalized labor induction care
Contact person: Hanna Castrén-Niemi
Batch: Fall 2022
A smart optical sensor for arthroscopic surgery
Contact person: Isaac Afara
Batch: Fall 2022
Graphene based dry electrodes for biometric measurements
Contact person: Teemu Ruotsalainen
Batch: Fall 2022
Protein production optimization
Contact person: Rashad Ismayilzada
Batch: Fall 2022
(Former ER4Surgery) Image-guided surgery without Instruments.
Contact person: Paavo Vartiainen
Batch: Fall 2022
A Novel Cell Growth Matrix by 3D Printing of Biopolymers
Contact person: Chunlin Xu
Batch: Spring 2022
Digital hearing diagnostics
Contact person: Aarno Dietz
Batch: Spring 2022
Light- reconfigurable substrate for cell cultures
Contact person: Arri Priimägi
Batch: Spring 2022
Mental health platform and services
Spin-out to Brightlife Oy
Contact person: Eero Haikonen
Batch: Spring 2022
Delivery of encapsulated mitochondria as novel pharmaceutical solution
Contact person: Hongbo Zhang
Batch: Spring 2022
Automated and scalable tool for precision diagnosis and personalized treatment
Contact person: Karolina Punovuori
Batch: Fall 2021
AI for the detection of heart transplant rejection
Contact person: Juha Peltonen
Batch: Fall 2021
Novel method for diagnosing respiratory suppression
Contact person: Antti Vehkaoja
Batch: Fall 2021
Non-invasive solution to support rehabilitation from AUD.
Got into SmiLe Incubator (Lund, SWE).
Contact person: Jukka Planman
Batch: Fall 2021
Diaper embedded biosensor platform, that screens abnormal clinical conditions
Contact person: Oguz Tanzer
Batch: Fall 2021
Prevention of pressure ulcers
Manager was recruited as Team Leader to Attendo.
Contact person: Nuno Nobre
Batch: Fall 2021
Viability analysis of organ transplants, and neuronal and cardiac implants
Contact person: Jarno Tanskanen
Batch: Fall 2021
MechScopy provides mechanical microscopy with the goal of making cancer 3D cell cultures reproducible and physiological.
Contact person: Juho Pokki
Batch: Fall 2021
How to make vaccines thermostable
Preparing to spin-out a startup.
Contact person: Manlio Fusciello
Batch: Spring 2021
Rapid diagnostics of human picornaviruses based on viral proteases
Contact person: Petri Susi
Batch: Spring 2021
Novel method for histology
Contact person: Ilkka Paatero
Batch: Spring 2021
mTMS – multilocus transcranial magnetic stimulation
Contact person: Kicic Dubravko
Batch: Spring 2021
Personalized prediction of the risk for aortic dilatation and rupture.
Preparing to spin-out a startup.
Contact person: Marja Hedman
Batch: Spring 2021
Poly(jasmine lactone): A Versatile Platform for Drug Delivery
Contact person: Kuldeep Bansal
Batch: 2020
Method for objective assessment of infant motor development.
Contact person: Sampsa Vanhatalo
Batch: 2020
Tissue specific therapy for skin diseases
Contact person: Tero Järvinen
Batch: 2020
Platform for optimized production of biotechnological proteins
Spin-out to Avenue Biosciences Oy and a startup in the U.S.
Contact person: Ville Paavilainen
Batch: 2020
Functional brain imaging reshaped
Contact person: Marko Havu
Batch: 2020
Smart heart monitoring.
Spin-out to Sonai Health Oy.
Contact person: Arto Kotimaa
Batch: 2020
Cardiac Micrograft Therapy™ for treating Ischhemic Scars and Heart Failure.
Spin-out to EpiHeart Oy.
Contact person: Kai Kronström
Batch: 2020
Accurate correction for QT interval ‒ the most important cardiac risk measure.
Spin-out to Monicardi Oy
Contact person: Esa Räsänen
Batch: 2020
Long-term oral drug delivery.
Alumni due Prof. Helder Santos got recruited as Head of Biomedical Engineering at UMCG (Groningen, NED).
Contact person:
Batch: 2020
Natural medication for human papillomavirus (HPV)-associated warts.
Spin-out to Anison Therapeutics Oy
Contact person: Preethy Paul
Batch: 2020
Functional insight into hypercholesterolemia patients.
Spin-out to Moncyte Oy
Contact person: Simon Pfisterer
Batch: 2020
Personalized treatment planning of osteoarthritis.
Spin-out to MSK Technologies Oy.
Contact person: Joona Kemppainen
Batch: 2020
Implantable support to treat pelvic organ prolapse.
Spin-out to Lignum Medical Oy
Contact person: Eija Raussi-Lehto
Batch: 2020
Indoor air diagnostics with fluorescent C. elegans nematodes.
Lead to a co-research project.
Contact person: Päivi Koskinen
Batch: 2019
Novel treatment for limbal epithelial stem cell deficiency.
Spin-out to StemSight Oy
Contact person: Laura Koivusalo
Batch: 2019
Therapeutics for antimicrobial resistant bacteria.
Spin-out to Arivin Therapeutics Oy, was accepted to INCATE Incubator.
Contact person: Christopher Jonkergouw
Batch: 2019
Distal radius fractures artificial intelligence diagnostic tool.
Preparations for a startup in progress.
Contact person: Jorma Ryhänen
Batch: 2019
Ultrasound solution for cancer biopsies
Spin-out/licensing under development.
Contact person: Jouni Rantanen
Batch: 2019
Simple droplet devices for biomedicine, diagnostics and pharma.
Got continuing development funding.
Contact person: Päivi Saavalainen
Batch: 2019
Vertigo diagnostics for primary care.
Got remarkable funding for another project.
Contact person: Tuomas Hyytiä
Batch: 2019
Diagnostic test for vitamin B3 metabolism deficiency.
Spin-out to NADMED Oy
Contact person: Liliya Euro
Batch: 2019
Topographically tuned and sustainable surfaces for biological applications.
Potential licensing case. Project manager got recruited as Innovation Manager at UTU.
Contact person: Erik Niemelä
Batch: Fall 2018
Laboratory and computational method for liquid biopsies.
Spin-out to Genomill Health Oy
Contact person: Manu Tamminen
Batch: Fall 2018
Rational discovery of protein-protein interaction modulators.
Spin-out to Aurlide Oy
Contact person: Olli Pentikäinen
Batch: Fall 2018
Parkinson’s signature biomarker assay.
Ongoing large validation study with Michael J Fox Foundation funding.
Contact person: Eleanor Coffey
Batch: Spring 2018
Light controlled protein production.
An alumni due Project Manager got recruited to Bayer.
Contact person: Jari Rossi
Batch: Spring 2018
Microbiome therapy for Parkinson’s disease.
IP turned into NeuroBiome Oy that has contract with a large company
Contact person: Filip Scheperjans
Batch: Spring 2018
Extra cellular vesicle solution for bleeding disorders.
An alumni due Project Manager got recruited to Mayo Clinic (USA).
Contact person: Mayank Saraswat
Batch: Spring 2018
Method for extra-cellular vesicle isolation.
Spin-out under establishment
Contact person: Maija Puhka
Batch: Spring 2018
Method to monitor the oxygenation of myocardial tissue.
Spin-out to SpectroCor Oy
Contact person: Kalle Kotilahti
Batch: Spring 2018
Novel heat treatment for age related macular degeneration.
Spin-out to Maculaser Oy
Contact person: Jani Tirronen
Batch: Spring 2018
Microbiome diagnostics for Parkinson’s disease.
IP turned to NeuroBiome Oy that has joint development and licensing agreement.
Contact person: Filip Scheperjans
Batch: Spring 2018
Mycobacterial biofilms as anti-tuberculosis drug targets.
Became a cornerstone of an extensive multinational research program.
Contact person: Mataleena Parikka
Batch: Spring 2018
Novel single cell omics methods.
Spin-out to Scellex Oy
Contact person: Päivi Saavalainen
Batch: Spring 2018
Light-activated antimicrobial surfaces and materials.
IP acquired by Plasmonics Oy
Contact person: Alexandre Efimov
Batch: Fall 2017
AI solution for toxicity testing.
Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.
Contact person: Dario Greco
Batch: Fall 2017
Laser solution for eye treatment.
Became a development case for industry.
Contact person: Jukka Viheriälä
Batch: Fall 2017
Toxicity test for heart cells.
Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.
Contact person: Tuula Heinonen
Batch: Fall 2017
Tissue analysis for breast cancer surgery.
Spin-out to Olfactomics Oy
Contact person: Antti Roine
Batch: Spring 2017
Ocular biomarker panel and analysis.
Project manager got recruited to another project.
Contact person: Ulla Aapola
Batch: Spring 2017
Microbiological Analyses on (Blue) Bio- and Circular Economies.
Spin-out to GreenSeq Oy
Contact person: Kirsi-Maarit Lehto
Batch: Spring 2017
Peritoneal diagnostics for dialysis patients.
Spin-out to Smart PD Solutions Oy
Contact person: Pirgit Silvast-Äikäs
Batch: Pilot 2016 / Spring 2017
Nano structure for bioimaging.
Spin-out to XFold Imaging Oy
Contact person: Timo Jäntti
Batch: Pilot 2016 / Spring 2017
Cancer drug for GIST.
Spin out to Sartar Therapeutics Oy
Contact person: Harri Sihto
Batch: Pilot 2016 / Spring 2017
Caries and infection prevention and treatment.
Spin-out to Koite Health Oy
Contact person: Tommi Pätilä
Batch: Pilot 2016 / Spring 2017
Safety mechanism for surgical drills.
Spin-out to Surgify Medical Oy
Contact person: Visa Sippola
Batch: Spring 2018
Microbiome therapy for Parkinson’s disease.
IP turned into NeuroBiome Oy that has contract with a large company
Contact person: Filip Scheperjans
Batch: Fall 2017
Tissue analysis for breast cancer surgery.
Spin-out to Olfactomics Oy
Contact person: Antti Roine
Batch: Pilot 2016 / Spring 2017
Nano structure for bioimaging.
Spin-out to XFold Imaging Oy
Contact person: Timo Jäntti
Batch: Pilot 2016 / Spring 2017
Caries and infection prevention and treatment.
Spin-out to Koite Health Oy
Contact person: Tommi Pätilä
Batch: Pilot 2016 / Spring 2017
Safety mechanism for surgical drills.
Spin-out to Surgify Medical Oy
Contact person: Visa Sippola
Batch: Fall 2018
Laboratory and computational method for liquid biopsies.
Spin-out to Genomill Health Oy
Contact person: Manu Tamminen
Batch: Fall 2018
Rational discovery of protein-protein interaction modulators.
Spin-out to Aurlide Oy
Contact person: Olli Pentikäinen
Batch: Spring 2018
Light controlled protein production.
An alumni due Project Manager got recruited to Bayer.
Contact person: Jari Rossi
Batch: Spring 2018
Extra cellular vesicle solution for bleeding disorders.
An alumni due Project Manager got recruited to Mayo Clinic (USA).
Contact person: Mayank Saraswat
Batch: Spring 2018
Novel single cell omics methods.
Spin-out to Scellex Oy
Contact person: Päivi Saavalainen
Batch: Fall 2017
Laser solution for eye treatment.
Became a development case for industry.
Contact person: Jukka Viheriälä
Batch: Spring 2017
Peritoneal diagnostics for dialysis patients.
Spin-out to Smart PD Solutions Oy
Contact person: Pirgit Silvast-Äikäs
Batch: Pilot 2016 / Spring 2017
Cancer drug for GIST.
Spin out to Sartar Therapeutics Oy
Contact person: Harri Sihto
Batch: 2019
Vertigo diagnostics for primary care.
Got remarkable funding for another project.
Contact person: Tuomas Hyytiä
Batch: Spring 2018
Method for extra-cellular vesicle isolation.
Spin-out under establishment
Contact person: Maija Puhka
Batch: Spring 2018
Method to monitor the oxygenation of myocardial tissue.
Spin-out to SpectroCor Oy
Contact person: Kalle Kotilahti
Batch: Spring 2018
Novel heat treatment for age related macular degeneration.
Spin-out to Maculaser Oy
Contact person: Jani Tirronen
Batch: Spring 2018
Mycobacterial biofilms as anti-tuberculosis drug targets.
Became a cornerstone of an extensive multinational research program.
Contact person: Mataleena Parikka
Batch: Spring 2018
Light-activated antimicrobial surfaces and materials.
IP acquired by Plasmonics Oy
Contact person: Alexandre Efimov
Batch: Fall 2017
Toxicity test for heart cells.
Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.
Contact person: Tuula Heinonen
Batch: Spring 2017
Ocular biomarker panel and analysis.
Project manager got recruited to another project.
Contact person: Ulla Aapola
Batch: Spring 2017
Microbiological Analyses on (Blue) Bio- and Circular Economies.
Spin-out to GreenSeq Oy
Contact person: Kirsi-Maarit Lehto
Batch: 2020
Cardiac Micrograft Therapy™ for treating Ischhemic Scars and Heart Failure.
Spin-out to EpiHeart Oy.
Contact person: Kai Kronström
Batch: 2020
Long-term oral drug delivery.
Alumni due Prof. Helder Santos got recruited as Head of Biomedical Engineering at UMCG (Groningen, NED).
Contact person:
Batch: 2020
Natural medication for human papillomavirus (HPV)-associated warts.
Spin-out to Anison Therapeutics Oy
Contact person: Preethy Paul
Batch: 2020
Personalized treatment planning of osteoarthritis.
Spin-out to MSK Technologies Oy.
Contact person: Joona Kemppainen
Batch: 2019
Novel treatment for limbal epithelial stem cell deficiency.
Spin-out to StemSight Oy
Contact person: Laura Koivusalo
Batch: 2019
Topographically tuned and sustainable surfaces for biological applications.
Potential licensing case. Project manager got recruited as Innovation Manager at UTU.
Contact person: Erik Niemelä
Batch: Spring 2018
Microbiome diagnostics for Parkinson’s disease.
IP turned to NeuroBiome Oy that has joint development and licensing agreement.
Contact person: Filip Scheperjans
Batch: Fall 2017
AI solution for toxicity testing.
Solution in use at FHAIVE, a reference toxicity laboratory for EURL ECVAM.
Contact person: Dario Greco
Batch: 2020
Smart heart monitoring.
Spin-out to Sonai Health Oy.
Contact person: Arto Kotimaa
Batch: 2020
Implantable support to treat pelvic organ prolapse.
Spin-out to Lignum Medical Oy
Contact person: Eija Raussi-Lehto
Batch: 2020
Indoor air diagnostics with fluorescent C. elegans nematodes.
Lead to a co-research project.
Contact person: Päivi Koskinen
Batch: 2019
Therapeutics for antimicrobial resistant bacteria.
Spin-out to Arivin Therapeutics Oy, was accepted to INCATE Incubator.
Contact person: Christopher Jonkergouw
Batch: 2019
Distal radius fractures artificial intelligence diagnostic tool.
Preparations for a startup in progress.
Contact person: Jorma Ryhänen
Batch: 2019
Ultrasound solution for cancer biopsies
Spin-out/licensing under development.
Contact person: Jouni Rantanen
Batch: 2019
Simple droplet devices for biomedicine, diagnostics and pharma.
Got continuing development funding.
Contact person: Päivi Saavalainen
Batch: 2019
Diagnostic test for vitamin B3 metabolism deficiency.
Spin-out to NADMED Oy
Contact person: Liliya Euro
Batch: Fall 2018
Parkinson’s signature biomarker assay.
Ongoing large validation study with Michael J Fox Foundation funding.
Contact person: Eleanor Coffey
Batch: Spring 2022
Mental health platform and services
Spin-out to Brightlife Oy
Contact person: Eero Haikonen
Batch: 2020
Platform for optimized production of biotechnological proteins
Spin-out to Avenue Biosciences Oy and a startup in the U.S.
Contact person: Ville Paavilainen
Batch: Fall 2021
Prevention of pressure ulcers
Manager was recruited as Team Leader to Attendo.
Contact person: Nuno Nobre
Batch: Fall 2021
How to make vaccines thermostable
Preparing to spin-out a startup.
Contact person: Manlio Fusciello
Batch: Spring 2021
Personalized prediction of the risk for aortic dilatation and rupture.
Preparing to spin-out a startup.
Contact person: Marja Hedman
Batch: 2020
Accurate correction for QT interval ‒ the most important cardiac risk measure.
Spin-out to Monicardi Oy
Contact person: Esa Räsänen
Batch: 2020
Functional insight into hypercholesterolemia patients.
Spin-out to Moncyte Oy
Contact person: Simon Pfisterer